Evidence map›Paper›PMID 35611496›Full record

ArticlePathology international2022

Elderly-onset systemic Epstein-Barr virus-positive T-cell lymphoma of childhood.

Masashi Nishikubo, Nobuhiro Hiramoto, Daisuke Yamashita, Hiroharu Imoto, Yoshitaka Sato, Yusuke Okuno, Hironori Haga, Yasuhito Nannya, Seishi Ogawa, Hiroshi Kimura and 1 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Pathology international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Masashi NishikuboDepartment of Hematology, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan.ORCID 0000-0002-6183-8910
Nobuhiro HiramotoDepartment of Hematology, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan.
Daisuke YamashitaDepartment of Pathology, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan.
Hiroharu ImotoDepartment of Hematology, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan.
Yoshitaka SatoDepartment of Virology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Yusuke OkunoDepartment of Virology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
Hironori HagaDepartment of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan.ORCID 0000-0003-4322-9561
Yasuhito NannyaDepartment of Hematology/Oncology, Research Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Seishi OgawaDepartment of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Hiroshi KimuraDepartment of Virology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Takayuki IshikawaDepartment of Hematology, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Epstein-Barr Virus InfectionsLymphoma, T-CellAgedHerpesvirus 4, HumanHumansImmunotherapyRNA, ViralRNA, Viral

Identifiers

PMID35611496
PMCPMC9542217

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.